Verve Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Verve Therapeutics stock had an average target of $14.57, with a low estimate of $11 and a high estimate of $24.

Price Target: $14.57 (+30.91%)

Analyst Consensus: Buy

Price Target

Target	Low	Average	Median	High
Price	$11	$14.57	n/a	$24
Change	-1.17%	+30.91%	n/a	+115.63%

Analyst Ratings

The average analyst rating for Verve Therapeutics stock from 11 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available

Rating	Oct 2026
Strong Buy	n/a
Buy	n/a
Hold	n/a
Sell	n/a
Strong Sell	n/a
Total	n/a

Financial Forecast

Revenue This Year

47.63M

from 32.33M

47.32%

from 32.33M

Revenue Next Year

23.36M

from 47.63M

-50.95%

from 47.63M

EPS This Year

-2.54

from -2.35

EPS Next Year

-3.00

from -2.54

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	1.94M	11.76M	32.33M	47.63M	23.36M
Revenue Growth	-	-	-	505.77%	174.98%	47.32%	-50.95%
EPS	-20.31	-4.48	-2.91	-3.12	-2.35	-2.54	-3.00
No. Analysts	-	-	-	-	-	11	10

Revenue Forecast

Revenue	2025	2026
High	75.8M	54.9M
Avg	47.6M	23.4M
Low	32.3M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	134.5%	15.3%
Avg	47.3%	-51.0%
Low	-0.0%	-

EPS Forecast

EPS	2025	2026
High	-2.27	-2.72
Avg	-2.54	-3.00
Low	-2.92	-3.73

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-